Citadel Advisors’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-288
Closed -$6.21K 15839
2022
Q4
$6.21K Buy
+288
New +$3.28K ﹤0.01% 13933
2022
Q1
Sell
-1,438
Closed -$238K 14905
2021
Q4
$238K Sell
1,438
-1,375
-49% -$238K ﹤0.01% 11478
2021
Q3
$501K Sell
2,813
-162
-5% -$32.9K ﹤0.01% 9859
2021
Q2
$563K Sell
2,975
-1,463
-33% -$249K ﹤0.01% 9797
2021
Q1
$853K Buy
4,438
+688
+18% +$160K ﹤0.01% 8499
2020
Q4
$806K Buy
3,750
+1,250
+50% +$279K ﹤0.01% 7245
2020
Q3
$580K Buy
2,500
+1,812
+263% +$522K ﹤0.01% 7027
2020
Q2
$225K Buy
+688
New +$145K ﹤0.01% 8359

Other funds holding VAPO

Citadel Advisors's VAPO Position: Q1 2023 in Review

Citadel Advisors sold out of Vapotherm, Inc. Common Stock (VAPO) in Q1 2023, closing a stake of 1,032 shares — an estimated $22.3K sold.

Citadel Advisors first reported a position in VAPO in Q1 2020 and held it in 11 quarters. The position peaked at $6.38M in Q2 2020. 51 funds tracked by Wall St. Rank hold VAPO as of Q1 2023.

  • Citadel Advisors reported no remaining Vapotherm, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,032 Vapotherm, Inc. Common Stock shares in Q1 2023, an estimated $22.3K.
  • Citadel Advisors first reported a position in Vapotherm, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Citadel Advisors's Vapotherm, Inc. Common Stock position peaked at $6.38M in Q2 2020.
  • 51 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.